Insight

Nelson Dusetti: Grateful to Institut National Du Cancer for funding through the PRT-K 2024 program

YouTube.com

Sep 9, 2024, 10:07

Nelson Dusetti: Grateful to Institut National Du Cancer for funding through the PRT-K 2024 program

Nelson Dusetti shared on X:

“Grateful to Institut National Du Cancer for funding through the PRT-K 2024 program!

This support helps us study treatment resistance in pancreatic cancer, strengthening the collaboration between CRCM – Cancer Research Centre of Marseille and Paoli-Calmettes Institute.”

Additional information.
Source: Nelson Dusetti/X

Nelson Dusetii is the Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.

cancer CRCM - Cancer Research Centre Institut national du cancer Nelson Dusetti. OncoDaily Oncology Paoli-Calmettes Institute Predicting Med PRT-K 2024 program

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage